Elutia (ELUT) Share-based Compensation (2019 - 2026)
Elutia recorded quarterly Share-based Compensation of $931000.0 in Q1 2026, up 6.77% quarter-over-quarter from $872000.0 in Q4 2025, and down 23.12% year-over-year from $1.2 million in Q1 2025.
Elutia's Share-based Compensation history runs 8 years deep, the most recent figure standing at $931000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 23.12% year-over-year to $931000.0; the TTM figure through Mar 2026 stood at $4.3 million (up 142.07% YoY), while the FY2025 annual figure was $5.2 million, up 137.0% from the prior year.
- Share-based Compensation came in at $931000.0 for Q1 2026 at Elutia, up from $872000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.7 million in Q2 2024 to a low of -$3.7 million in Q4 2024.
- A 5-year average of $833705.9 and a median of $931000.0 in 2026 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 299.26% in 2024 and fell as far as 751.5% in 2024.
- Elutia's Share-based Compensation stood at $630000.0 in 2022, then retreated by 10.32% to $565000.0 in 2023, then tumbled by 751.5% to -$3.7 million in 2024, then surged by 123.69% to $872000.0 in 2025, then increased by 6.77% to $931000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $931000.0, $872000.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 931,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 931,000.00 |
| Mar 31, 2026 | 931,000.00 |
| Dec 31, 2025 | -1.94 Mn |
| Dec 31, 2025 | -1.94 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 565,000.00 |
| Dec 31, 2023 | 565,000.00 |
| Sep 30, 2023 | 566,000.00 |
| Sep 30, 2023 | 566,000.00 |
| Jun 30, 2023 | 679,000.00 |
| Jun 30, 2023 | 679,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Dec 31, 2022 | 630,000.00 |
| Dec 31, 2022 | 630,000.00 |
| Sep 30, 2022 | 219,000.00 |
| Sep 30, 2022 | 219,000.00 |
| Jun 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 973,000.00 |
| Dec 31, 2021 | 973,000.00 |
| Sep 30, 2021 | 999,000.00 |
| Sep 30, 2021 | 999,000.00 |
| Jun 30, 2021 | 885,000.00 |
| Jun 30, 2021 | 885,000.00 |
| Mar 31, 2021 | 677,000.00 |
| Mar 31, 2021 | 677,000.00 |
| Dec 31, 2020 | 593,000.00 |
| Dec 31, 2020 | 593,000.00 |
| Sep 30, 2020 | 59,000.00 |
| Sep 30, 2020 | 59,000.00 |
| Jun 30, 2020 | 72,000.00 |
| Jun 30, 2020 | 72,000.00 |
| Mar 31, 2020 | 54,000.00 |
| Mar 31, 2020 | 54,000.00 |
| Dec 31, 2019 | 52,000.00 |
| Dec 31, 2019 | 52,000.00 |